Successful Rezafungin Treatment of an Azole-Resistant Chronic Mucocutaneous Candidiasis in a STAT-1 Gain-of-Function Patient

J Clin Immunol. 2023 Aug;43(6):1182-1184. doi: 10.1007/s10875-023-01519-2. Epub 2023 May 29.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / therapeutic use
  • Azoles* / pharmacology
  • Azoles* / therapeutic use
  • Candidiasis, Chronic Mucocutaneous* / drug therapy
  • Candidiasis, Chronic Mucocutaneous* / genetics
  • Echinocandins
  • Gain of Function Mutation
  • Humans

Substances

  • Rezafungin
  • Azoles
  • Echinocandins
  • Antifungal Agents